Company Overview of Institut Mérieux SA
Institut Mérieux SA, through its subsidiaries, develops new approaches in the fields of diagnostics, immunotherapy, food safety, and nutrition to treat infectious diseases, cancers, and metabolic disorders in France and internationally. The company develops and markets in vitro diagnostic solutions for medical and industrial applications; designs and develops therapeutic vaccines and immunotherapy products to treat cancers and infectious diseases; and develops food products that offer health benefits. It also develops, produces, and distributes systems and reagents for in vitro diagnosis that are used by monitoring laboratories for microbiological quality control in agri-food, pharmaceutical...
17 Rue Bourgelat
Founded in 1897
Key Executives for Institut Mérieux SA
Director General Delegate
Vice President of Medical and Scientific Affairs
Compensation as of Fiscal Year 2014.
Institut Mérieux SA Key Developments
Institut Mérieux Announces Executive Changes, Effective October 1, 2013
Sep 10 13
Dr. Marc Bonneville has been appointed Vice-President in charge of Medical and Scientific Affairs at Institut Mérieux. Starting October 1, 2013, he will be taking over from Prof. Christian Bréchot, who has been called upon to lead the Institut Pasteur. Dr. Bonneville will be responsible for pursuing and expanding the activities instigated by Prof. Bréchot, in particular with respect to the Mérieux Research Grants program, multidisciplinary research projects, and various joint activities between the group's companies at an international level. Dr. Bonneville is co-founder and member of scientific advisory boards for various companies in the field of biotechnology and healthcare and has extensive experience of industrial partnerships.
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries